All Outputs (2)

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis (2021)
Journal Article
Chetty, S., Armstrong, T., Sharma Kharkwal, S., Drewe, W. C., De Matteis, C. I., Evangelopoulos, D., Bhakta, S., & Thomas, N. R. (2021). New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis. Pharmaceuticals, 14(4), Article 361. https://doi.org/10.3390/ph14040361

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has reinforced the need for the development of new anti-TB drugs. The first line drug isoniazid inhibits InhA. This is a prodrug requiring activation by... Read More about New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis.

An integrated dyspepsia module for first year Pharmacy students: a flexible and generic template for integrating science with clinical and professional practice (2017)
Journal Article
De Matteis, C. I., Randall, M. D., Harvey, E. J., Morris, A., Winkler, G. S., & Boardman, H. F. (2019). An integrated dyspepsia module for first year Pharmacy students: a flexible and generic template for integrating science with clinical and professional practice. American Journal of Pharmaceutical Education, 83(1), Article 6508. https://doi.org/10.5688/ajpe6508

Objective: To design an integrated dyspepsia module for first year pharmacy undergraduates, which combines clinical and professional practice with fundamental sciences, in five different science subject areas, as a prototype for future disease- or sy... Read More about An integrated dyspepsia module for first year Pharmacy students: a flexible and generic template for integrating science with clinical and professional practice.